ReviewInternational journal of clinical oncology2025

Revisiting resectability of biliary tract cancers, in the triplet drug therapy era with immune checkpoint inhibitors.

Shogo Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.